Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVN461 in Noninfectious Anterior Uveitis
NCT06679153Phase 2Completed
- Sponsor
- VivaVision Biotech
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VVN461 in non-infectious anterior uveitis, sponsored by VivaVision Biotech. Started Nov 2023; status: completed.
02
Drugs
VVN461
03
Conditions
non-infectious anterior uveitis
Beyond the preview
Go deeper on NCT06679153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679153.